論文 - 田坂 定智
-
ARDSの疾患フェノタイプと治療
田坂 定智
ICUとCCU 45(3) 149 - 153 2021年
-
加熱式たばこ・電子たばこの肺障害
田坂 定智
臨床リハ 30(10) 1051 - 1055 2021年
-
The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study.
Dobashi M, Tanaka H, Taima K, Itoga M, Ishioka Y, Shiratori T, Okumura F, Tabe C, Tanaka Y, Morimoto T, Hasegawa Y, Yasugahira H, Okudera K, Takanashi S, Tasaka S
SAGE open medicine 9 20503121211023357 2021年
-
日本臨床 領域別症候群シリーズ 腫瘍性疾患 「Pancoast症候群」
田中 寿志、田坂 定智
肺癌診療ガイドライン 2021年度版 2021年
-
The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study.
Dobashi M, Tanaka H, Taima K, Itoga M, Ishioka Y, Shiratori T, Okumura F, Tabe C, Tanaka Y, Morimoto T, Hasegawa Y, Yasugahira H, Okudera K, Takanashi S, Tasaka S
SAGE open medicine 9 20503121211023357 - 20503121211023357 2021年
-
Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study).
Kei Morikawa, Hisashi Tanaka, Hidetoshi Itani, Saori Takata, Satoshi Watanabe, Kazuma Kishi, Kenzo Soejima, Kyoichi Kaira, Hiroshi Kagamu, Kenichi Yoshimura, Noriyuki Matsutani, Nobuhiko Seki
Therapeutic advances in medical oncology 12 1758835920967254 - 1758835920967254 2020年10月
-
A Phase I/II Study of Biweekly Carboplatin and Nab-paclitaxel With Concurrent Radiotherapy for Patients With Locally Advanced Unresectable Stage III Non-small-cell Lung Cancer.
Hisashi Tanaka, Yukihiro Hasegawa, Tomonori Makiguchi, Fumihiko Okumura, Chiori Tabe, Toshihiro Shiratori, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Junichi Yokouchi, Yoshiomi Hatayama, Masahiko Aoki, Sadatomo Tasaka
Clinical lung cancer 22 ( 1 ) 42 - 48 2020年10月
-
Effect of nintedanib on non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review.
Toshihiro Shiratori, Hisashi Tanaka, Chiori Tabe, Junichiro Tsuchiya, Yoshiko Ishioka, Masamichi Itoga, Kageaki Taima, Shingo Takanashi, Sadatomo Tasaka
Thoracic cancer 11 ( 6 ) 1720 - 1723 2020年06月
-
Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab.
Kageaki Taima, Hisashi Tanaka, Masamichi Itoga, Yoshiko Ishioka, Akira Kurose, Sadatomo Tasaka
Respirology case reports 8 ( 5 ) e00580 - e00580 2020年05月
-
ISG56 is involved in CXCL10 expression induced by TLR3 signaling in BEAS-2B bronchial epithelial cells.
Toshihiro Shiratori, Tadaatsu Imaizumi, Koji Hirono, Shogo Kawaguchi, Tomoh Matsumiya, Kazuhiko Seya, Sadatomo Tasaka
Experimental lung research 46 ( 6 ) 195 - 202 2020年05月
-
A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer
Tanaka H, Tabe C, Okumura F, Shiratori T, Ishioka Y, Itoga M, Taima K, Morimoto T, Kimura D, Tsushima T, Tasaka S.
Thorac Cancer 11 1633 - 1638 2020年04月
-
Recent Advances in the Diagnosis and Management of Pneumocystis Pneumonia.
Tasaka S
Tuberculosis and respiratory diseases 83 ( 2 ) 132 - 140 2020年04月
-
繰り返す血胸・気胸を契機に診断された血管型Ehlers-Danlos症候群
石岡佳子，白鳥俊博，當麻景章，糸賀正道，林 周次郎，田坂定智
日呼吸誌 9 ( 6 ) 473 - 476 2020年
-
ニボルマブが有効であった大細胞神経内分泌癌の1例
田辺 千織, 田中 寿志, 當麻 景章, 糸賀 正道, 白鳥 俊博, 田坂 定智
肺癌 59 ( 7 ) 1156 - 1161 2019年12月
-
特集 高齢者の呼吸器感染症治療-症例が示すマネジメントの最前線 ◉肺真菌症 ③ニューモシスチス
田坂 定智
感染と抗菌薬 22 ( 4 ) 280 - 284 2019年12月
-
Simultaneous Detection of the T790M and L858R Mutations in the EGFR Gene by Oligoribonucleotide Interference-PCR
Keisuke Baba, Toshitsugu Fujita, Sadatomo Tasaka, Hodaka Fujii
International Journal of Molecular Sciences 20 ( 16 ) 2019年08月
-
特集 今日の呼吸器診療と今後の展望 知っておきたい呼吸器疾患 急性呼吸窮迫症候群(ARDS)
田坂 定智
内科 124 ( 1 ) 1459 - 1461 2019年07月
-
Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice.
Ho Namkoong, Makoto Ishii, Hideki Fujii, Takahiro Asami, Kazuma Yagi, Shoji Suzuki, Shuhei Azekawa, Sadatomo Tasaka, Naoki Hasegawa, Tomoko Betsuyaku
Biochemical and Biophysical Research Communications 513 ( 2 ) 405 - 411 2019年05月
-
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer.
Hisashi Tanaka, Kageaki Taima, Masamichi Itoga, Yoshiko Ishioka, Keisuke Baba, Toshihiro Shiratori, Hiroaki Sakamoto, Junichiro Tsuchiya, Hideyuki Nakagawa, Yukihiro Hasegawa, Hideo Yasugahira, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
Medical oncology 36 ( 6 ) 57 - 57 2019年05月
-
The efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring driver mutations.
Sakamoto H, Tanaka H, Shiratori T, Baba K, Ishioka Y, Itoga M, Taima K, Hasegawa Y, Takanashi S, Tasaka S.
Molecular and Clinical Oncology 10 ( 6 ) 610 - 614 2019年04月